TMO — Thermo Fisher Scientific

Health Care · NYSE/Nasdaq. Last price 669.54 USD (-2.79% on the day). Raven's AI 12-month target: 755.00 USD. Updated 2026-11-20.

Paper-trade Thermo Fisher Scientific free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 755.00 USD (+9.62% from 688.75 when it was set on 2026-11-20). Conviction: medium.

Catalysts: Laboratory instrument demand; Biopharma M&A tailwind

Risks: Biotech funding tightness; Pricing pressure on assays

Earnings

Q3 2026 earnings per share: 6.68 USD against 6.40 expected (beat by 4.3%). EPS estimates for 2026: 25.28 USD (27 analysts), 2027: 27.79 USD (27 analysts). The 2026 estimate has moved +0.6% over 90 days.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical

RAVEN is taking longer than usual to load.
RELOAD